IP Verse

Composition Comprising Epa And Dha For An Enhanced Efficacy Of Anticancer Agents - EP3525781

The patent EP3525781 was granted to Fresenius Kabi Deutschland on Apr 24, 2024. The application was originally filed on Oct 5, 2017 under application number EP17780718A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3525781

FRESENIUS KABI DEUTSCHLAND
Application Number
EP17780718A
Filing Date
Oct 5, 2017
Status
Patent Maintained As Amended
Mar 22, 2024
Grant Date
Apr 24, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

NUTRICIAOct 27, 2021VO -

Patent Citations (10) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2003068385
DESCRIPTIONUS6750048
DESCRIPTIONWO0176385
DESCRIPTIONWO0176715
DESCRIPTIONWO2012028543
INTERNATIONAL-SEARCH-REPORTUS2003068385
INTERNATIONAL-SEARCH-REPORTWO2012028543
OPPOSITIONWO2007075841
OPPOSITIONWO2012033538
OPPOSITIONWO2015113986

Non-Patent Literature (NPL) Citations (13) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
INTERNATIONAL-SEARCH-REPORT- AGNIHOTRI N ET AL, "Fish oil increases the chemotherapeutic efficacy of 5-Fluorouracil by altering the membrane characteristics and drug uptake", EUROPEAN JOURNAL OF CANCER, & EUROPEAN CANCER CONGRESS 2015 / 18TH MEETING OF THE EUROPEAN-CANCER-ORGANIZATION (ECCO) / 40TH MEETI; VIENNA, AUSTRIA; SEPTEMBER 25 -29, 2015, (201509), vol. 51, no. Suppl. 3, page S385, XP002767899 [A] 1-13 * abstract *
INTERNATIONAL-SEARCH-REPORT- SALA-VILA A ET AL, "The effect of three lipid emulsions differing in fatty acid composition on growth, apoptosis and cell cycle arrest in the HT-29 colorectal cancer cell line", CLINICAL NUTRITION, CHURCHILL LIVINGSTONE, LONDON, GB, vol. 29, no. 4, ISSN 0261-5614, (20100801), pages 519 - 524, (20091128), XP027178516 [A] 1-13 * table 1 * * page 519, abstract *
INTERNATIONAL-SEARCH-REPORT- YANG TING ET AL, "N-3 PUFAs have antiproliferative and apoptotic effects on human colorectal cancer stem-like cells in vitro", THE JOURNAL OF NUTRITIONAL BIOCHEMISTRY, ELSEVIER, AMSTERDAM, NL, (20120731), vol. 24, no. 5, doi:10.1016/J.JNUTBIO.2012.03.023, ISSN 0955-2863, pages 744 - 753, XP028586045 [A] 1-13 * page 749, column r, paragraph 4. * * page 753, left-hand column, last paragraph *
INTERNATIONAL-SEARCH-REPORT- GRANCI VIRGINIE ET AL, "Colon cancer cell chemosensitisation by fish oil emulsion involves apoptotic mitochondria pathway", BRITISH JOURNAL OF NUTRITION, (201304), vol. 109, no. 7, pages 1188 - 1195, XP002767900 [A] 1-13 * page 1188, abstract *
OPPOSITION- "4.4.1.1 Eicosapentaenoic Acid", NAGI B. KUMAR, Nutritional Management of cancer Treatment Effects, Berlin / Heidelberg, Springer, (20180218), pages 70 - 71, XP055861217
OPPOSITION- Anonymous, "Fish Oil", Chemical Book, (2017), URL: https://www.chemicalbook.com/ChemicalProductProperty_EN_CB5128501.htm, XP055861210
OPPOSITION- GAVHANE Y. N. et al., "Solid Tumors: Facts, Challenges and Solutions", International Journal of Pharma Sciences and Research (IJPSR), (20110100), vol. 2, no. 1, pages 1 - 12, XP055861195
OPPOSITION- MORLAND et al., "n-3 polyunsaturated fatty acid supplementation during cancerchemotherapy", Journal of Nutrition & Intermediary Metabolism, (20160527), vol. 5, pages 10 - 116
OPPOSITION- Rachel A. Murphy; Marina Mourtzakis; Quincy S. C. Chu; Vickie E. Baracos; Tony Reiman; Vera C. Mazurak, "Supplementation with fish oil increases first‐line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer", Cancer, American cancer society , Philadelphia , PA, US, US , (20110215), vol. 117, no. 16, doi:10.1002/cncr.25933, ISSN 0008-543X, pages 3774 - 3780
OPPOSITION- Rachel A. Murphy; Marina Mourtzakis; Quincy S. C. Chu; Vickie E. Baracos; Tony Reiman; Vera C. Mazurak, "Supplementation with fish oil increases first‐line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer", Cancer, American cancer society , Philadelphia , PA, US, US , (20110215), vol. 117, no. 16, doi:10.1002/cncr.25933, ISSN 0008-543X, pages 3774 - 3780, XP071039079
OPPOSITION- MORLAND et al., "n-3 polyunsaturated fatty acid supplementation during cancerchemotherapy", Journal of Nutrition & Intermediary Metabolism, (20160527), vol. 5, pages 10 - 116, XP055861198
OPPOSITION- G Ramesh, U.N Das, "Effect of cis-unsaturated fatty acids on Meth-A ascitic tumour cells in vitro and in vivo", CANCER LETTERS, NEW YORK, NY, US, US , (19980101), vol. 123, no. 2, doi:10.1016/S0304-3835(97)00426-6, ISSN 0304-3835, pages 207 - 214, XP055302906
OPPOSITION- D'ELISEO et al., "Omega-3 Fatty Acids and Cancer Cell Cytotoxicity: Implications for Multi-Targeted Cancer Therapy", Journal of Clinical Medicine, (20160126), vol. 5, no. 2, page 15, XP055861204

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents